Search results
Shengxian Tu
Author
William Fearon
Research Area(s) / Expertise:
Job title: Professor of Medicine, Director of Interventional Cardiology
Author
Author(s):
Frederik Zimmermann
Added:
1 year ago
EuroPCR 23 – In this late-breaking science interview, we are joined by Prof Frederick Zimmermann (Catharina Hospital, NL) to discuss the findings from a 3-year follow-up of the FAME III trial.
The objective of the FAME 3 trial was to demonstrate the noninferiority of fractional flow reserve (FFR)-guided percutaneous coronary intervention (PCI) compared to coronary artery bypass grafting (CABG)…
View more
Author(s):
Bhavik Modi
,
Subhabrata Dutta
,
Damien Collison
,
et al
Added:
7 months ago
Author(s):
Felix Böhm
Added:
10 months ago
ACC.24 — Investigator, Dr Felix Böhm (Danderyd Hospital, SE) joins us to discuss the findings from a study investigating fractional flow reserve-guided complete or culprit-only percutaneous coronary intervention (PCI) in patients with ST-elevation myocardial infarction (MI).1542 patients were enrolled in the trial, who were randomized 1:1 to receive either FFR-guided PCI of non-culprit lesions…
View more
Author(s):
Daniele Andreini
Added:
4 months ago
With focus on the 2024 ESC chronic coronary syndromes (CCS) guidelines – that highlighted significant advancements in the recommendations for fractional flow reserve computed tomography (FFRct) and coronary computed tomography angiography (CTA) – this insightful series aims to equip healthcare professionals with the latest clinical strategies and practical tools for integrating FFRct and coronary…
View more
Author(s):
Hirofumi Ohashi
,
Frédéric Bouisset
,
Dimitri Buytaert
,
et al
Added:
1 year ago
Benjamin Scott
Job title: MD
Author
Author(s):
Johny Nicolas
,
Nicholas L Pitaro
,
Birgit Vogel
,
et al
Added:
1 year ago
Author(s):
Breda Hennessey
,
Asad Shabbir
,
Alejandro Travieso
,
et al
Added:
1 year ago